A research paper by scientists from Southern University of Science and Technology developed a near-infrared (NIR) light-activated biomimetic nanomotor for targeted nitric oxide (NO) delivery and synergistic cancer therapy.

The new research paper, published on Apr. 24 in the journal Cyborg and Bionic Systems, developed a new light‑activated nanomotor platform combines photothermal therapy, chemodynamic therapy, and nitric oxide (NO) gas therapy in one tiny, tumor‑hunting vehicle.

Researchers at Bar-Ilan University have successfully restored youthful patterns of DNA organization in the livers of old mice, reversing key molecular features associated with aging.

The study, published in Nature Communications, identifies the protein SIRT6 as a powerful protector against age-related breakdown in chromatin, the complex system that packages DNA and controls how genes are switched on and off.

The findings suggest that aging is not simply a passive process of wear and tear but may be driven in part by reversible changes in the way DNA is organized inside cells.

Hutchinson-Gilford progeria syndrome (HGPS) is a rare genetic condition characterized by accelerated aging, severe vascular fragility, and reduced life expectancy. In a rare case study, researchers report a traumatic brain injury case in a 15-year-old adolescent with HGPS, where conventional management methods failed, owing to no curative therapies for HGPS and limited benefits from lonafarnib. The report concludes by stressing the need for improved multidisciplinary trauma care strategies when managing patients with HGPS.

Tumor cells exploit chemokine signaling to construct an immunosuppressive microenvironment that resists anti-tumor immune responses. A new review systematically maps the chemokine-receptor network in the tumor microenvironment and introduces a three-part “3D” targeting strategy: Decrease recruitment of suppressive cells (Tregs, MDSCs, TAMs), Develop effector T cell and NK cell function, and Dismantle physical and signaling barriers that exclude effectors from tumors. This framework ultimately provides a roadmap for precision combination immunotherapy to overcome immune evasion

As AI is being widely tested in medicine, scientists at the University of Auckland, Auckland City Hospital, and Matai Medical Research Institute in New Zealand have analyzed the current landscape of AI models for meningioma (a cancer of the brain’s soft cover) segmentation from MRI scans, and its path ahead. Their key finding is that advanced model architecture has considerably contributed to tumor detection sensitivity, rather than data characteristics, imaging modalities, or preprocessing.